Receptor tyrosine kinases in sinonasal undifferentiated carcinomas--evaluation for EGFR, c-KIT, and HER2/neu expression

Head Neck. 2009 Jul;31(7):919-27. doi: 10.1002/hed.21061.

Abstract

Background: Our objective was to identify the expression of epidermal growth factor receptor (EGFR), c-KIT (CD117), and HER2/neu in sinonasal undifferentiated carcinoma (SNUC).

Methods: Immunohistochemistry for c-KIT (CD117), EGFR, and HER2/neu was performed on paraffin-embedded tissue from SNUC cases. A search for activating mutations in c-kit exons 9, 11, 13, and 17 or gene amplification was undertaken by high-resolution DNA melting curve analysis and fluorescence in situ hybridization (FISH) for c-kit and chromosome 4, respectively.

Results: By immunohistochemistry, 9 of 11 cases (81.8%) were diffusely (4+) positive for c-KIT, 3 of 11 cases (27.3%) were positive for EGFR, and none of the cases were positive for HER2/neu. Neither activating mutations nor gene amplification of c-kit were detected in any of the 8 assessable tumors.

Conclusion: c-KIT is frequently expressed in SNUC. However, the overexpression is not due to activating mutations or gene amplification.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma / enzymology*
  • Carcinoma / genetics*
  • Carcinoma / pathology
  • Cohort Studies
  • Female
  • Humans
  • In Situ Hybridization, Fluorescence
  • Male
  • Middle Aged
  • Mutation / genetics*
  • Paranasal Sinus Neoplasms / enzymology*
  • Paranasal Sinus Neoplasms / genetics*
  • Paranasal Sinus Neoplasms / pathology
  • Polymerase Chain Reaction
  • Receptor Protein-Tyrosine Kinases / physiology*
  • Retrospective Studies

Substances

  • Receptor Protein-Tyrosine Kinases